Summary
Rapid arrest of T cells at target sites upon engagement of chemokine receptors is crucial to the proper functioning of the immune system. Although T cell arrest always occurs under hydrodynamic forces in vivo, most studies investigating the molecular mechanisms of arrest have been performed under static conditions. While the requirement of the adaptor protein SLP-76 in TCR-induced integrin activation has been demonstrated, its role in chemokine-triggered T cell adhesion is unknown. Using a flow chamber system, we show that SLP-76 plays an important role in regulating the transition from tethering and rolling to firm adhesion of T cells under physiological shear flow in response to CXCL12α SDF-1α); SLP-76-deficient primary T cells exhibited defective adhesion with a significant decrease in the number of firmly arrested cells. We further demonstrate the N-terminal phosphotyrosines of SLP-76 play a critical role in this T cell adhesion under flow. These findings reveal a novel role for SLP-76 in CXCR4-mediated T lymphocyte trafficking.
Keywords: SLP-76, Chemokine, T lymphocyte, Firm arrest, Shear flow, LFA-1
Introduction
A successful immune response relies on rapid changes in the adhesive properties of T cells to allow arrest and subsequent migration to secondary lymphoid organs (SLOs) or inflammatory sites. Intravascular T cells are subjected to the shear stresses of blood flow, requiring multiple adhesive and chemotactic events for cells to exit blood vessels. These processes result from integration of mechanical and biochemical signals initiated by engagement of selectins, integrins, and chemokine receptors, on both T cells and host tissues [1–4].
Entry of T cells to inflammatory sites requires a complex multistep process. In response to inflammatory stimuli, cells are first captured by weak binding to P- or E-selectin expressed on the inflamed vascular endothelium, resulting in tethering and rolling adhesion. Exposure to chemokines present on the vessel wall leads to rapid activation of integrins on T cells and to firm adhesion through binding of these integrins to their ligands. Subsequent actin reorganization following the enhancement of integrin activity contributes to shear-resistant firm arrest [5]. Within seconds to minutes of firm arrest, adherent T cells extravasate and eventually transmigrate to the site of inflammation.
During the transition to adhesion, multiple signaling pathways are activated inside the cell. Key among these are signals downstream of chemokine receptors and signaling to and by integrins. Circulating T cells maintain the integrin lymphocyte function-associated protein-1 (LFA-1; also known as α1Lβ2) in a closed and non-adhesive state. Chemokines or TCR activation triggers “inside-out” signaling, which induces LFA-1 activation leading to up-regulation of its ligand-binding affinity and avidity. Once the open and activated LFA-1 binds to its ligand, signaling events collectively designated “outside-in” signaling ensue [6].
In TCR-induced integrin activation, SLP-76 (SH2-domain containing leukocyte-specific phosphoprotein of 76 kDa) is a key mediator of inside-out signaling [7]. TCR stimulation induces the recruitment of SLP-76 to the phosphorylated transmembrane adapter protein linker for activation of T cells (LAT) via its binding partner Grb2-related adapter downstream of Shc (Gads) [8]. This multi-component signaling complex containing LAT, Gads, and SLP-76 is recruited to the plasma membrane, resulting in association of activated effector proteins and reorganization of the actin cytoskeleton.
We recently showed that SLP-76 is recruited to the plasma membrane by the LFA-1 ligation with ICAM-1, indicating that SLP-76 also functions in outside-in signaling downstream of integrins [9]. However, it is unclear whether SLP-76 additionally plays a role in chemokine-mediated integrin inside-out activation and subsequent T cell adhesion. Although it has been shown that SLP-76 is required for CXCL12α-induced intracellular Ca2+ mobilization and Erk activation [10, 11], LAT and the binding of Gads/SLP-76 to LAT have not been implicated in this process. We and others confirmed that the LAT/Gads/SLP-76 complex is neither assembled nor recruited to the plasma membrane in response to LFA-1 ligation or CXCL12α binding in T cells [9, 12]. These data imply that SLP-76 may have different roles in outside-in integrin signaling or chemokine-induced inside-out integrin activation compared to TCR-stimulated inside-out integrin activation.
In this study, we address whether SLP-76 plays a role in CXCR4-mediated T cell adhesion. To mimic physiological environment, we used a flow chamber system in which cells are exposed to continuous shear flow while undergoing the tethering, rolling, and adhesion cascade. Primary T cells deficient in SLP-76 show defective chemokine-induced integrin-mediated firm adhesion under shear flow. Furthermore, we demonstrate that N-terminal phosphotyrosines of SLP-76 are important in regulating T cell arrest under shear flow in response to stimulation by immobilized CXCL12α. Our data thus suggest that SLP-76 plays a critical role in chemokine-induced firm arrest of T cells under physiological shear conditions.
Results and Discussion
SLP-76 is required for optimal CXCL12α-induced T cell firm arrest on ICAM-1 under shear flow
To investigate the role of SLP-76 in CXCL12α-induced firm arrest under shear flow, we first analyzed cell adhesion using Jurkat T cells, a model system that has been a reliable surrogate for primary T cells in many studies investigating T cell signaling and function [13]. Jurkat cells were flowed over immobilized P-selectin/ICAM-1/CXCL12α under a wall shear rate of 100 s−1 (Fig. 1A(i)). Adherent cells were classified as tethered, rolling, or firmly arrested based on their instantaneous velocities and the duration of their stopping (Fig. 1A(ii)). In response to immobilized CXCL12α, SLP-76 deficient J14 cells exhibited a significant reduction in firm arrest and a correspondingly increased tethering and rolling population, compared to WT cells (Fig. 1B and C). Since re-expression of WT SLP-76 in the J14 clone does not rescue the defect in firm arrest or migration in transwell assays (Fig. 1B and C) [11], we analyzed the surface expression levels of integrin αL (CD11a) of these cells using flow cytometry. As shown in Fig. 1D, the integrin αL levels of both J14 and SLP-76 retransfected J14 cells were 4-fold lower than that of WT Jurkat cells. We found that the lack of firm arrest of both cell types was well correlated with the inherent defect in the amount of integrin αL expression. Therefore, we explored the role of SLP-76 for adhesion by “knocking down” SLP-76 expression using RNA interference in WT Jurkat cells. As shown in Fig. 2A, we achieved 80% knock-down using three sequential electroporations of a mix of two siRNAs specific for SLP-76. We found that individual SLP-76 siRNA treatment also significantly lowered the expression levels of SLP-76, indicating that the SLP-76 knock-down using the SLP-76 mix was a specific on-target silencing. When introduced to immobilized CXCL12α under shear flow, SLP-76 knocked-down Jurkat cells showed a substantial decrease in the percentage of firmly arrested cells (36% compared to 52% of the control, Fig. 2B). In addition, for the SLP-76 knocked-down cells that did arrest, the time to stop was significantly decreased and the rolling velocity increased (Fig. 2C). These observations indicate that SLP-76 is necessary for optimal activation of LFA-1 and adhesion stabilization in the gradual transition from rolling to arrest.
Based on the results obtained with cell lines, we next investigated the role of SLP-76 in T cell arrest under flow using primary T cells. Flow chamber experiments were performed with primary T cells from WT or SLP-76 conditional knockout (cKO) mice. The arrest of primary T cells on surfaces immobilized with ICAM-1/CXCL12α was classified as either “transient arrest” or “stable arrest”, because selectin which induces rolling adhesion was not applied in these experiments. Arrest sustained for more than 40 s in this study is termed stable arrest. SLP-76 cKO T cells exhibited a significant decrease in stable arrest at 100 s−1 compared to WT T cells (Fig. 2D). These data along with our previous work [9] demonstrate that SLP-76 deficiency in murine T cells decreases the number of stably arrested cells on ICAM-1 in response to immobilized CXCL12α under physiological shear flow, indicating that SLP-76 appears to be required for the transition from transient adhesion to firm adhesion.
In contrast with our results, Horn et al. [12] recently reported that deletion of SLP-76 by siRNA transfection in human T cells did not affect CXCL12α-induced T cell chemokinesis and transwell migration, nor did it affect the ability of T cells to bind either soluble or immobilized ICAM-1. We speculate that the discrepancy in results might be due to differences in assay conditions. Continuous shear forces employed in our study might prevent the unstable adherent cells from becoming firmly arrested, while under static conditions it is possible that T cells in contact with ICAM-1 could activate alternative signaling pathways that do not require SLP-76.
Role of the N-terminal tyrosines of SLP-76 in T cell firm arrest on ICAM-1 under shear flow
The SLP-76 N-terminal tyrosines are critical for its function in TCR signaling [14]. The Y112 and Y128 residues are required for binding to the guanine nucleotide exchange factor, Vav1 and the adapter protein, Nck [14, 15]. Y145 is crucial for the interaction of SLP-76 with Tec family tyrosine kinase IL-2-inducible T cell kinase (Itk) [16]. To examine the role of these N-terminal tyrosines in CXCL12α-induced LFA-1-mediated firm arrest of T cells under shear flow, we analyzed the adhesion of T cells from mutant mice where tyrosine residues were mutated to phenylalanine (Y112/118F or Y145F). Both Y112/128F and Y145F T cells exhibited defective arrest on P-selectin/ICAM-1/CXCL12α-surfaces compared to WT cells (Fig. 3A). In addition, T cells from both SLP-76 Y-F knock-in (KI) lines demonstrated a greater proportion that undergo tethering and rolling compared to WT cells in response to immobilized CXCL12α, suggesting that these mutations lead to defects in the transition from transient adhesion to firm arrest in CXCR4-induced activation. In the absence of immobilized chemokine, the majority of cells simply tethered or rolled (Fig. 3A). When firmly arrested cells were further analyzed for time and distance to stop, we found that the Y-F KI T cells were weakly adherent, indicated by long stop times and rolling distance before stopping (Fig. 3B and C), suggesting that LFA-1-ICAM-1-mediated firm arrest is impaired in both Y-F KI T cells. To ensure that the SLP-76 dependent effects on adhesion were due to impaired signaling through engaged receptors and not due to a global defect in the SLP-76 deficient cells, we bypassed the receptor-mediated signaling by stimulating WT and SLP-76 Y-F KI T cells with PMA. As shown in Fig. 3D, this completely rescued the adhesion defect in the mutant T cells.
Collectively, our data show that the adapter protein, SLP-76, plays a critical role in the gradual transition of CXCR4-engaged T cell arrest on ICAM-1 under shear flow using an in vitro flow chamber. It is likely that SLP-76 is important in local signaling events in which chemokine receptors engaged with surface-bound chemokines transmit the instantaneous signal to proximal β2 integrins undergoing rapid increase in adhesiveness to ICAM-1 under flow, as demonstrated by Alon and co-workers [17, 18]. Interestingly, Zarbock and colleagues recently showed that SLP-76 is also involved in global signaling events in which neutrophil binding to E-selectin induces progressive activation of LFA-1 without chemokine stimulation [19]. Further studies are necessary to understand how SLP-76 discerns or integrates two signaling networks to enhance integrin avidity and leukocyte arrest. In addition, we find that the SLP- 76 N-terminal tyrosines are important in CXCL12α-triggered and ICAM-1-mediated T lymphocyte adhesion under shear flow by enhancing integrin affinity and stabilizing T cell arrest. The work by Teixidó’s group has established that T cell exposure to CXCL12 activates Vav1-Rac signaling [20]. This group also demonstrated that Vav1 dissociation from talin under CXCL12 stimulation leads to integrin α4β1 activation and T cell adhesion [21]. Our work adds further potential mechanism to the function of Vav1 as a molecular linker and implies that Vav1 must associate with SLP-76 for efficient integrin αLβ2- mediated T cell adhesion.
Modulating integrin-mediated cell adhesion is an attractive strategy for the treatment of inflammatory and autoimmune diseases. While antibodies blocking integrin-ligand binding have shown therapeutic success not only in animal models but in humans for treatment of psoriasis, multiple sclerosis and Crohn’s disease [22–24], this complete and non-specific interference of integrin function has led to a number of serious side effects [25, 26]. An alternative approach is to modulate integrin signaling by targeting molecules in the integrin activation pathway. Our study further reveals the critical role of SLP-76 in integrin signaling, not only in both TCR-mediated inside-out and outside-in pathways, as previously shown, but also in chemokine-induced integrin-mediated cell adhesion. Future studies investigating the functional domains and cellular localization of SLP-76, through which it functions in the distinct integrin signaling pathways, will help better understand the mechanisms of integrin activation and the design of therapeutic strategies to modulate integrin function in a more precise manner.
Materials and methods
Western blot analysis, flow cytometry, data acquisition, and cell tracking and analysis are described in the Supporting Information.
Cell lines and mice
Jurkat T cells (E6-1 clone), SLP-76-deficient stable Jurkat cells, J14, and J14 retransfected with WT SLP-76 have been described previously [13]. SLP-76 cKO and SLP-76 Y-F KI mice (Y112/128F and Y145F) have been described previously [9, 27, 28]. Mouse handling and procedures were in strict accordance with University of Pennsylvania and IACUC protocols. Primary T cells from spleens of 6-8-week-old mice were purified by negative selection and magnetic separation (Miltenyi Biotec, Auburn, CA). Cells were activated by plate-bound anti-CD3 (1 μg/ml; eBioscience, San Diego, CA) and anti-CD28 (5 μg/ml; eBioscience) in IMDM medium (supplemented with 10% FBS) for 2–3 days.
siRNA transfection
Jurkat cells (ATCC, Manassas, VA) were maintained in RPMI1640 medium supplemented with 10% FBS at 37°C with 5% CO2. For electroporation of siRNA, E6-1 cells were resuspended in 100 μl resuspension buffer R (Invitrogen, Carlsbad, CA). a mix of two siRNAs (SLP-76 (1,2))(SLP-76 (1): SASI_Hs01_00219492 and SLP-76 (2): SASI_Hs01_00219493 from Sigma-Aldrich, St. Louis, MO) against SLP-76 (official symbol: LCP2; gene ID: 3937) or Cy3-labeled negative control #1 siRNA (Ambion, Cat #: AM4621, Austin, TX) was added to 2×106 cells/transfection (with a 100 μl electroporation pipet tip). Within 10 min, cells were transfected by electroporation (pulse voltage: 1,350 V; pulse width: 10 ms; pulse number: 3 with MicroPorator MP-100 from Digital-Bio, Hopkinton, MA). The cells were then added to prewarmed cell culture medium, as described above. The transfection was repeated at 24 and 48 h, and cells were used at 72 h for Western blotting and flow chamber experiments.
Flow chamber assays
Cell adhesion assays were performed in a parallel-plate flow chamber (GlycoTech, Gaithersburg, MD). Polystyrene Petri dishes (Corning 430588, Corning, NY) enclosed using a single well flexiPERM (Sigma-Aldrich) were coated with a mixed solution of 2 μg/ml Protein A/G (Thermo Scientific, Rockford, IL) and 1 μg/ml CXCL12α (R&D Systems, Minneapolis, MN) at 4°C overnight. The surfaces were then washed with 1% BSA in PBS. A mixture of 0.2 μg/ml P-selectin/Fc and 0.4 μg/ml ICAM-1/Fc (for primary T cells; 2 μg/ml P-selectin/Fc and 4 μg/ml ICAM-1/Fc for Jurkat cells transfected with siRNA; 2 μg/ml P-selectin/Fc and 8 μg/ml ICAM-1/Fc for E6-1, J14 and J14 + WT SLP-76) was applied to the surfaces and allowed to bind the Protein A/G-coated surfaces at room temperature for 3 h. The surfaces were then blocked for non-specific adhesion with 2% BSA in PBS at room temperature for 1 h. An assembled flow chamber was mounted on an inverted microscope, Axiovert 200 (Carl Zeiss, Gottingen, Germany) enclosed by a microscope incubator, XL-3 (Carl Zeiss) to perform the flow chamber experiments at 37°C. The T cells (5×105/ml) were perfused into the chamber at a flow rate corresponding to a calculated wall shear rate of 100 s−1. Adhesion of T cells on immobilized P-selectin/ICAM-1 in response to immobilized CXCL12α was observed using phase contrast microscopy under a 10× objective (NA = 0.20; Type: A-Plan). Adherent T lymphocytes were classified as tethering, rolling, or firmly arrested cells based on their instantaneous velocities and the duration of their stopping.
Statistical Analyses
Data were analyzed by unpaired and one-tailed Student’s t-test for comparisons between two sets or one-way analysis of variance (ANOVA), followed by Tukey-Kramer test for multiple comparisons. In both analyses, the minimum acceptable level of significance was P < 0.05.
Acknowledgments
This work was supported by NIH 1R01AI082292-01 (D.A.H and G.A.K). D.L. was supported by the American Heart Association postdoctoral fellowship 09POST2140195.
Abbreviations
- cKO
conditional knockout
- Gads
Grb2-related adapter downstream of Shc
- Itk
IL-2-inducible T cell kinase
- KI
knock-in
- LAT
linker for activation of T cells
- LFA-1
lymphocyte function-associated protein-1
- N.S
not statistically significant
- SDF-1α
stromal cell-derived factor-1α
- SLO
secondary lymphoid organ
- SLP-76
Src homology 2-domain containing leukocyte-specific phosphoprotein of 76 kDa
Footnotes
Disclosures
The authors have no financial conflict of interest.
References
- 1.Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol. 2005;42:799–809. doi: 10.1016/j.molimm.2004.06.040. [DOI] [PubMed] [Google Scholar]
- 2.Sackstein R. The lymphocyte homing receptors: gatekeepers of the multistep paradigm. Curr Opin Hematol. 2005;12:444–450. doi: 10.1097/01.moh.0000177827.78280.79. [DOI] [PubMed] [Google Scholar]
- 3.Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008;20:525–532. doi: 10.1016/j.ceb.2008.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Campbell DJ, Kim CH, Butcher EC. Chemokines in the systemic organization of immunity. Immunol Rev. 2003;195:58–71. doi: 10.1034/j.1600-065x.2003.00067.x. [DOI] [PubMed] [Google Scholar]
- 5.Gomez TS, Billadeau DD. T cell activation and the cytoskeleton: you can't have one without the other. Adv Immunol. 2008;97:1–64. doi: 10.1016/S0065-2776(08)00001-1. [DOI] [PubMed] [Google Scholar]
- 6.Hogg N, Patzak I, Willenbrock F. The insider's guide to leukocyte integrin signalling and function. Nat Rev Immunol. 2011;11:416–426. doi: 10.1038/nri2986. [DOI] [PubMed] [Google Scholar]
- 7.Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591–619. doi: 10.1146/annurev.immunol.021908.132706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Liu SK, Fang N, Koretzky GA, McGlade CJ. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr Biol. 1999;9:67–75. doi: 10.1016/s0960-9822(99)80017-7. [DOI] [PubMed] [Google Scholar]
- 9.Baker RG, Hsu CJ, Lee D, Jordan MS, Maltzman JS, Hammer DA, Baumgart T, Koretzky GA. The adapter protein SLP-76 mediates "outside-in" integrin signaling and function in T cells. Mol Cell Biol. 2009;29:5578–5589. doi: 10.1128/MCB.00283-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fischer AM, Mercer JC, Iyer A, Ragin MJ, August A. Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase ITK. J Biol Chem. 2004;279:29816–29820. doi: 10.1074/jbc.M312848200. [DOI] [PubMed] [Google Scholar]
- 11.Ottoson NC, Pribila JT, Chan AS, Shimizu Y. Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase. J Immunol. 2001;167:1857–1861. doi: 10.4049/jimmunol.167.4.1857. [DOI] [PubMed] [Google Scholar]
- 12.Horn J, Wang X, Reichardt P, Stradal TE, Warnecke N, Simeoni L, Gunzer M, Yablonski D, Schraven B, Kliche S. Src homology 2-domain containing leukocyte-specific phosphoprotein of 76 kDa Is mandatory for TCR-mediated inside-out signaling, but dispensable for CXCR4-mediated LFA-1 activation, adhesion, and migration of T cells. J Immunol. 2009;183:5756–5767. doi: 10.4049/jimmunol.0900649. [DOI] [PubMed] [Google Scholar]
- 13.Abraham RT, Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol. 2004;4:301–308. doi: 10.1038/nri1330. [DOI] [PubMed] [Google Scholar]
- 14.Jordan MS, Sadler J, Austin JE, Finkelstein LD, Singer AL, Schwartzberg PL, Koretzky GA. Functional hierarchy of the N-terminal tyrosines of SLP-76. J Immunol. 2006;176:2430–2438. doi: 10.4049/jimmunol.176.4.2430. [DOI] [PubMed] [Google Scholar]
- 15.Bubeck Wardenburg J, Pappu R, Bu JY, Mayer B, Chernoff J, Straus D, Chan AC. Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. Immunity. 1998;9:607–616. doi: 10.1016/s1074-7613(00)80658-5. [DOI] [PubMed] [Google Scholar]
- 16.Su YW, Zhang Y, Schweikert J, Koretzky GA, Reth M, Wienands J. Interaction of SLP adaptors with the SH2 domain of Tec family kinases. Eur J Immunol. 1999;29:3702–3711. doi: 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
- 17.Alon R, Grabovsky V, Feigelson S. Chemokine induction of integrin adhesiveness on rolling and arrested leukocytes local signaling events or global stepwise activation? Microcirculation. 2003;10:297–311. doi: 10.1038/sj.mn.7800195. [DOI] [PubMed] [Google Scholar]
- 18.Shamri R, Grabovsky V, Gauguet JM, Feigelson S, Manevich E, Kolanus W, Robinson MK, Staunton DE, von Andrian UH, Alon R. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol. 2005;6:497–506. doi: 10.1038/ni1194. [DOI] [PubMed] [Google Scholar]
- 19.Block H, Herter JM, Rossaint J, Stadtmann A, Kliche S, Lowell CA, Zarbock A. Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury. J Exp Med. 2012;209:407–421. doi: 10.1084/jem.20111493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Garcia-Bernal D, Wright N, Sotillo-Mallo E, Nombela-Arrieta C, Stein JV, Bustelo XR, Teixido J. Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1. Mol Biol Cell. 2005;16:3223–3235. doi: 10.1091/mbc.E04-12-1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Garcia-Bernal D, Parmo-Cabanas M, Dios-Esponera A, Samaniego R, Hernan PdlOD, Teixido J. Chemokine-induced Zap70 kinase-mediated dissociation of the Vav1-talin complex activates alpha4beta1 integrin for T cell adhesion. Immunity. 2009;31:953–964. doi: 10.1016/j.immuni.2009.09.021. [DOI] [PubMed] [Google Scholar]
- 22.Lew EA, Stoffel EM. Natalizumab for active Crohn's disease. N Engl J Med. 2003;348:1599. doi: 10.1056/NEJM200304173481615. author reply 1599. [DOI] [PubMed] [Google Scholar]
- 23.Chaudhuri A, Behan PO. Natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003;348:1598–1599. doi: 10.1056/NEJM200304173481614. author reply 1598–1599. [DOI] [PubMed] [Google Scholar]
- 24.Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med. 2003;349:2004–2013. doi: 10.1056/NEJMoa030002. [DOI] [PubMed] [Google Scholar]
- 25.Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med. 2005;353:362–368. doi: 10.1056/NEJMoa051586. [DOI] [PubMed] [Google Scholar]
- 26.Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005;353:375–381. doi: 10.1056/NEJMoa051847. [DOI] [PubMed] [Google Scholar]
- 27.Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, Koretzky GA. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science. 1998;281:416–419. doi: 10.1126/science.281.5375.416. [DOI] [PubMed] [Google Scholar]
- 28.Maltzman JS, Kovoor L, Clements JL, Koretzky GA. Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection. J Exp Med. 2005;202:893–900. doi: 10.1084/jem.20051128. [DOI] [PMC free article] [PubMed] [Google Scholar]